Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$376.42NASDAQ Previous Close - Last Trade as of 3:59PM ET 12/13/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$368.00 (1)
Ask (Size)$379.28 (5)
Day Low / HighN/A - N/A
Volume995.9 K

Insider Trends: Insider 90-Day Selling Trend Extended at Regeneron Pharmaceuticals

5:02PM ET 9/12/2019 MT Newswires
Sanofi, 10% Owner, on Sep 10, 2019, sold 172,904 shares in Regeneron Pharmaceuticals (REGN) for $48,611,804. Subsequent to the Form 4 filing with the SEC, Sanofi has control over 23,350,365 shares of company stock of which 20,550,813 shares are held directly and 2,799,552 are controlled indirectly. These holdings have an approximate market value of $6,616 million as of the prior-day closing price.

This is the first insider transaction for the company in the last 90 days. This compares with the preceding 90-day window of time where there were 11 transactions from 5 insiders which resulted in the net acquisition of 73,428 shares.

This is less than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Within the peer group activity averaged 37.5 transactions per company, with company insiders acquiring on average 15,767 shares.

SEC Story Link